ProQR Therapeutics

PRQR

ProQR Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel Anton de Boer, with a market cap of $244.1M.

Market cap

$244.14M+8.8%

We’re still putting together ProQR Therapeutics’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move ProQR Therapeutics up the queue, and we’ll analyze its filings next.